Concepedia

Mark Matson

MM

Statistics

Publications

14

Citations

892

H-Index

12

Active since

1988

Affiliations

Prism Clinical Research(Current)

Biogen (United States)

Hennepin County Medical Center

Rho (United States)

Astellas Pharma (United States)

Mark Matson is an author at Prism Clinical Research specializing in medicine, pharmacology, and clinical pharmacology.

Publications per year

1988–2021

14

Publications

14

Acquired Cystic Kidney Disease

Mark Matson, Eric P. Cohen · Medicine · 1990 · 249 citations

, , +4

Effects of AMG 145 on Low-Density Lipoprotein Cholesterol Levels

Clapton Dias, Adam J. Shaywitz, Scott M. Wasserman et al. · Journal of the American College of Cardiology · 2012 · 234 citations

, , +12

TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study

Ciarán P. Kelly, Joseph A. Murray, Daniel A. Leffler et al. · Gastroenterology · 2021 · 177 citations · Full text

, , +16

Pharmacokinetics and Pharmacodynamics of MK‐5046, a Bombesin Receptor Subtype‐3 (BRS‐3) Agonist, in Healthy Patients

Marc L. Reitman, Victor Dishy, Allison Moreau et al. · The Journal of Clinical Pharmacology · 2011 · 44 citations

, , +13

Pharmacokinetics and Safety of FV-100, a Novel Oral Anti-Herpes Zoster Nucleoside Analogue, Administered in Single and Multiple Doses to Healthy Young Adult and Elderly Adult Volunteers

Helen S. Pentikis, Mark Matson, George Atiee et al. · Antimicrobial Agents and Chemotherapy · 2011 · 37 citations · Full text

, , +14

1–5 of 14